Using chemical biomarkers released by the brain immediately after a head injury occurs, researchers are able to pinpoint when patients need urgent medical attention. This saves time in delivering vital treatment and avoids patients undergoing unnecessary tests where no injury has occurred.
The technique was developed by a multi-disciplinary team of researchers in the group of Advanced Nanomaterials, Structures, and Applications (ANMSA) led by Dr Goldberg Oppenheimer at the University of Birmingham.
Following a proof-of-concept study, the group has now completed Innovate UK’s commercialisation programme, iCURE, to identify commercialisation routes for the technique, identifying potential partners across eight countries.
The … Read More »